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ABSTRACT
Objectives: The objectives of this study were to determine the impact of renal dosing guidelines on prescribing pattern for nonsteroidal anti-
inflammatory drugs and antibiotic in patients with chronic kidney disease (CKD).
Methods: This was a prospective interventional study. The study was divided into two phases, pre-intervention and post-intervention phases. Data 
regarding the kidney function and the pattern of drug dosing will record in the pre-intervention phase. Pocket guides were prepared for the drug 
dosing in renal impairment and were distributed to clinicians and the pharmacist as a part of intervention. In the post-intervention phase, the dosing 
pattern of renal eliminated drugs was observed for any improvement. The patterns of dosing of renal eliminated drugs were compared in both the 
phases.
Results: In pre-interventional phase, a total of 43 cases were reviewed, 20 of them were non-hemodialysis (non-HD) (9 female and 11 male) cases 
with a mean±standard deviation (SD) age of 56.05+8.22 (56) and 23 were undergoing HD (11 female and 12 male) cases with a mean±SD age of 
56.72+6.85 (56). In the post-intervention phase, a total of 41 cases were reviewed, 22 of them were non-HD (12 female and 10 male) cases with a 
mean±SD age of 55.85+6.87 (57) and 19 were undergoing HD (10 female and 9 male) cases with a mean±SD age of 55.77+8.39 (56.6).
Conclusion: Health-care professionals have an important responsibility in monitoring the dose for renal impairment patients. Development of renal 
dosing guidelines for patients hospitalized with CKD can improve the pattern of prescribing in renal failure population.
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INTRODUCTION
The kidneys are bean-shaped organs found on the left and right sides 
of the body in vertebrates [1,2]. The nephron is the structural and 
functional unit of the kidney. Each adult kidney contains around one 
million nephrons. The nephron utilizes four processes to alter the 
blood plasma which flows to it: Filtration, reabsorption, secretion, 
and excretion [3,4]. The kidneys also carry out functions independent 
of the nephron. For example, they convert a forerunner of Vitamin D 
to its active form, calcitriol, and synthesize the hormones such as 
erythropoietin and renin [5,6]. Renal physiology was the study of 
kidney function. Nephrology is the medical specialty which addresses 
diseases of kidney function, which include chronic kidney disease 
(CKD), nephritis and nephritic syndrome, acute kidney injury, and 
pyelonephritis. Urology addresses diseases of the kidney (and urinary 
tract) anatomy which include cancer, renal cysts, kidney stones and 
ureteral stones, and urinary tract obstruction [7,8]. Dialysis and 
kidney transplantation are used to treat kidney failure; one (or both 
sequentially) of these are almost always used when renal function 
drops below 15%. Nephrectomy was frequently used to cure renal cell 
carcinoma [9,10].
METHODS
This was a prospective interventional study. Subjects will be recruited 
according to selection criteria. A structured data collection form 
is designed to collect the information from the case sheets of the 
patients. The study was divided into two phases, pre-intervention and 
post-intervention phases. Data regarding the kidney function and the 
pattern of drug dosing will record in the pre-intervention phase. Pocket 
guides were prepared for the drug dosing in renal impairment and were 
distributed to clinicians and the pharmacist as a part of intervention. 
In the post-intervention phase, the dosing pattern of renal eliminated 
drugs was observed for any improvement. The patterns of dosing 
of renal eliminated drugs were compared in both the phases. Ethical 
committee approval no. VISTAS-SPS/IEC/IV/2017/07.
RESULTS
In the pre-interventional phase, a total of 43 cases were reviewed, 20 
of them were non-hemodialysis (non-HD) (9 female and 11 male) cases 
with a mean±standard deviation (SD) age of 56.05+8.22 (56) and 23 
were undergoing HD (11 female and 12 male) cases with a mean±SD age 
of 56.72+6.85 (56). In the post-intervention phase, a total of 41 cases 
were reviewed, 22 of them were non-HD (12 female and 10 male) cases 
with a mean±SD age of 55.85+6.87 (57) and 19 were undergoing HD 
(10 female and 9 male) cases with a mean±SD age of 55.77+8.39 (56.6) 
(Table 1). The number of drugs that prescribed was found to be 479. 
The number of nonsteroidal anti-inflammatory drugs (NSAIDs) and 
Antibiotics prescribed was found to be 59 for non hemodyalitic patients 
and 57 for hemodyalitic patient. The number of NSAIDs that required 
dose adjustments was found to be 13 for non-HD patients and 11 for HD 
patients. The number of antibiotics that required dose adjustments was 
found to be 16 for non-HD patients and 17 for HD patients. (Table 2). 
As a part of intervention study, pocket guides were prepared for the 
NSAIDs and antibiotic drug dosing in renal impairment and were 
distributed to the clinician. Post-intervention, the number of drugs that 
prescribed was found to be 410. In that, the total number of NSAIDs and 
antibiotics prescribed was found to be 65 for non-HD patients and 62 
for HD patients. The number of NSAIDs that required dose adjustments 
was found to be 6 for non-HD patients and 9 for HD patients. The 
number of antibiotics that required dose adjustments was found to 
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be 8 for non-HD patients and 6 for HD patients. (Table 2). The type of 
dosage adjustments needed was found to be dose reduction in 46% (28 
drugs) of the drugs for pre-intervention phase and 37.9% (11 drugs) in 
post-intervention, change of dosing interval in 40% (24 drugs) of the 
drugs in pre-intervention and 27.5% (8 drugs) in post-intervention, 
and about 13.3% (8 drugs) in pre-intervention and 34.4% (10 drugs) 
in post-intervention which were not recommended for the prescribing 
in renal function (Table 3). By comparing the results of post- and pre-
intervention phases, it is clear that there is a significant impact of the 
dosing guidelines in the form of pocket guides in improving the dosing 
pattern of the renally eliminated drugs. The rate of inappropriateness 
in dosing was significantly reduced in post-intervention phase as 
compared to pre-intervention phase. Inappropriateness in dosing was 
significantly reduced in antibiotics from 77.27% to 49.76% (p=0.0287*) 
in non-HD patients and NSAIDs reduced its inappropriateness of dosing 
from 63.15% to 28.57% in non-HD patients (p=0.0163*). Furthermore, 
inappropriateness in dosing was significantly reduced in antibiotics 
from 84.21% to 33.33% in HD patients (p=0.0090**) and NSAIDs 
reduce its inappropriateness in dosing from 63.63% to 50% in HD 
patients (Table 4).
DISCUSSION
By comparing the results of post- and pre-intervention phases, it 
is clear that there is a significant impact of the dosing guidelines 
in the form of pocket guides in improving the dosing pattern of the 
renally eliminated drugs. The rate of inappropriateness in dosing 
was significantly reduced in post-intervention phase as compared to 
pre-intervention phase. Inappropriateness in dosing was significantly 
reduced in antibiotics from 77.27% to 49.76% (p=0.0287*) in non-HD 
patients and NSAIDs reduced its inappropriateness of dosing from 
63.15% to 28.57% in non-HD patients (p=0.0163*). Furthermore, 
inappropriateness in dosing was significantly reduced in antibiotics 
from 84.21% to 33.33% in HD patients (p=0.0090**) and NSAIDs 
reduce its inappropriateness in dosing from 63.63% to 50% in HD 
patients
Table 1: Demographic profile of study population
Demographics Pre‑intervention Post‑intervention
Non‑HD (20) HD (23) Non‑HD (22) HD (19)
Gender
Female (%) 9 (45) 11 (47.82) 12 (54.54) 10 (52.63)
Male (%) 11 (55) 12 (52.17) 10 (45.45) 9 (47.36)
Age
Mean+SD (median) 56.05+8.22 (56) 56.72+6.85 (56) 55.85+6.87 (57) 55.77+8.39 (56.6)
Serum creatinine
Mean+SD (median) Serum creatinine 5.03+2.01 (5.2) 5.33+2.37 (5.2) 5.18+1.90 (5.2) 5.00+1.72 (4.9)
Non-HD: Non-hemodialysis, SD: Standard deviation
Table 2: Number of medications prescribed in study population
Category Pre‑intervention Post‑intervention
Non‑HD HD Non‑HD HD
Total number of prescriptions 20 23 22 19
Total number of drug prescribed 212 259 217 203
Total number of NSAIDs and antibiotics prescribed 59 57 65 62
Number of antibiotics dosed appropriately 18 15 28 23
Number of NSAIDs dosed appropriately 12 11 23 24
Number of NSAIDs dosed in appropriately 13 (63.15%) 14 (63.63%) 6 (28.57%) 9 (50%)
Number of antibiotic dose in appropriately 16 (84.21%) 17 (77.27%) 8 (49.76%) 6 (33.33%)
NSAIDs: Nonsteroidal anti-inflammatory drugs, Non-HD: Non-hemodialysis
Table 3: Details of the type of dosing adjustment needed
Type of adjustment Pre‑intervention Post‑intervention
Number of drugs, n=60 (%) Number of drugs, n=29 (%)
Dose reduction 28 (46.6) 11 (37.9)
Change in dosing interval 24 (40) 8 (27.5)
not recommended 8 (13.3) 10 (34.4)
Table 4: Impact of pocket guide on dosing adjustments
Parameters Pre‑intervention Post‑intervention p value
Total Inappropriate (%) Total Inappropriate (%)
In non-HD 25 13 (63.15) 29 6 (28.57) 0.0163*
NSAIDs
Antibiotics 34 16 (77.27) 36 8 (49.76) 0.0287*
In HD patients 25 14 (63.63) 33 9 (50) 0.0268*
NSAIDs
Antibiotics 32 17 (84.21) 29 6 (33.33) 0.0090
NSAIDs: Nonsteroidal anti-inflammatory drugs, Non-HD: Non-hemodialysis
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CONCLUSION
The prevalence of CKD is increasing and polypharmacy is common. 
There is a need to monitor the dosing of drugs in those patients to avoid 
the adverse effects, to reduce the length of stay in the hospital, and 
to control the unnecessary cost of medications Antibiotic and NSAID 
prescriptions required dosage adjustment based on patient’s renal 
function. Health-care professionals have an important responsibility 
in monitoring the dose for renal impairment patients. Development of 
renal dosing guidelines for patients hospitalized with CKD can improve 
the pattern of prescribing in renal failure population
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